SCHEMBL1824916

SCHEMBL1824916

CS(=O)(=O)Oc1ccc(CC(CNC(=O)OCc2ccccc2)C(=O)OCc2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.50
PTPN1 P18031 1/20 0.47
PPARA Q07869 3/20 0.46
MAPT P10636 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
ACHE P22303 1/20 0.44
CA12 O43570 2/20 0.43
CA9 Q16790 2/20 0.43
SYK P43405 1/20 0.43
CTSL P07711 1/20 0.42
CTSB P07858 1/20 0.42
CTSS P25774 1/20 0.42
CTSK P43235 1/20 0.42
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CTRB1 P17538 2/20 0.42
LTA4H P09960 1/20 0.41
LAP3 P28838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1826715 0.95 PPARG (0.53) PPARGPTPN1PPARAMAPTL3MBTL1
SCHEMBL1827040 0.94 PPARG (0.49) PPARGPTPN1PPARAMAPTL3MBTL1
SCHEMBL1826541 0.92 PPARG (0.47) PPARGPTPN1PPARAMAPTL3MBTL1
SCHEMBL3575553 0.91 PPARG (0.50) PPARGPTPN1PPARACA1CA2
SCHEMBL1826119 0.91 SYK (0.54) PPARGPPARAMAPTSYKP2RX7
SCHEMBL1828002 0.91 SYK (0.52) PPARGPTPN1PPARAMAPTL3MBTL1
SCHEMBL3563937 0.88 P2RX7 (0.49) PTPN1MAPTL3MBTL1P2RX7
SCHEMBL1826143 0.88 CASP3 (0.43) PPARGPTPN1PPARA
SCHEMBL1825506 0.87 PPARG (0.50) PPARGPPARACA1CA2ACHE
SCHEMBL1823835 0.86 P2RX7 (0.58) PTPN1MAPTP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 PPARG 3864/4885PTPN1 963/4885PPARA 3865/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 PPARG 2131/4885PTPN1 4064/4885PPARA 2339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.